Abstract
Background and study aim Use of endoscopic ultrasound-guided biliary drainage (EUS-BD) has recently increased.
In EUS-BD, after puncturing the bile duct, dilation is performed and the stent is
deployed. Due to adverse events (AEs) such as unexpected displacement of the guidewire,
simplified procedures are required. Currently, stents with small-diameter delivery
systems are being rapidly developed, expanding the possibilities for of EUS-BD without
dilation. In this retrospective study, we aimed to evaluate the success rates and
AEs in patients who underwent EUS-guided hepaticogastrostomy (EUS-HGS) or EUS-guided
hepaticojejunostomy (EUS-HJS) without dilation.
Patients and methods Six consecutive patients with malignant biliary obstruction and failed transpapillary
BD underwent EUS-HGS or EUS-HJS without dilation, deploying a 6-mm fully-covered self-expandable
metallic stent with a 6-Fr delivery system.
Results The technical and clinical success rates were 100 %. There was one case each of stent
migration and stent occlusion, and no other AEs were noted.
Conclusions EUS-HGS or EUS-HJS without dilation using a stent with a 6-Fr delivery system had
high technical and clinical success rates; however, additional cases are required
to validate the study findings.